glp-1 kidney function Potential renoprotective effects of GLP1 receptor agonists. The GLP-1 Agonism for Kidney Transplant

Lpez-Otn C, Blasco MA, Partridge L, Serrano M, Kroemer G (2023) Hallmarks of aging: an expanding universe

When exposed to palatable food compared to non-palatable food, GLP-1 levels did not change significantly in obese patients (Rigamonti et al., 2015)

Clinical trial data showed patients taking oral Wegovy lost an average of 13.6% of body weight at 71 weeks, while comparable injectable GLP-1 trials have shown average weight loss to be between 15% to 20%

[DOI] [PubMed] [Google Scholar] 81.Mortensen H, Kocova M, Teng LY, Keiding J, Bruckner I, Philotheou A

[DOI] [PMC free article] [PubMed] [Google Scholar] El Bekay R., Con-Aragez L., Fernndez-Garca D., Oliva-Olivera W., Bernal-Lpez R., Clemente-Postigo M., et al

SA--galactosidase assay in tumour samples Tumour samples frozen in OCT were cryosectioned at 15 M